Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 CAD | -0.34% | +0.69% | +1.91% |
03-11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
03-11 | Dexterra Upgraded to Outperform at Raymond James | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- With a P/E ratio at 11.18 for the current year and 9.42 for next year, earnings multiples are highly attractive compared with competitors.
- The company shows low valuation levels, with an enterprise value at 0.4 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Hotels, Motels & Cruise Lines
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.91% | 274M | B- | ||
+8.59% | 49.44B | B | ||
+10.49% | 15.96B | A- | ||
+14.26% | 15.07B | C+ | ||
+18.01% | 10.92B | A- | ||
+31.85% | 9.84B | A- | ||
+11.86% | 5.05B | A | ||
+3.83% | 4.37B | C- | ||
+23.60% | 3.8B | B+ | ||
+88.02% | 3.58B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXT Stock
- Ratings Dexterra Group Inc.